Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05383404
Other study ID # Soh-Med-22-05-11
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 25, 2022
Est. completion date June 2023

Study information

Verified date March 2023
Source Sohag University
Contact mohamed A ismail, resident
Phone 01009852166
Email mohammad.esmaeel@med.sohag.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Diabetic ketoacidosis (DKA) is a common acute complication of type 1 diabetes mellitus (T1DM). DKA is characterized by hyperglycemia, metabolic acidosis, increased levels of ketone bodies in blood and urine. This leads to osmotic diuresis and severe depletion of water and electrolytes from both the intra- and extracellular fluid (ECF) compartments. Estimation of the degree of dehydration for children admitted with DKA is of great clinical importance. The calculation of the amount of deficit therapy depends on the estimated degree of dehydration. However, the degree of dehydration present during DKA is difficult to be clinically assessed. Hyperosmolality tends to preserve intravascular volume with maintenance of peripheral pulses, blood pressure, and urine output until extreme volume depletion occurs. Metabolic acidosis leads to hyperventilation and dry oral mucosa as well as decreased peripheral vascular resistance and cardiac function . consequently, hyper-osmolality may lead to an underestimation of the degree of dehydration, whereas metabolic acidosis may lead to an overestimation of the degree of dehydration. This makes the physical findings unreliable in this setting. Several clinical and biochemical markers were suggested to assess and stage the degree of dehydration at hospital admission. The blood urea nitrogen , hematocrit , plasma albumin are useful markers of the degree of ECF contraction.However, Several previous studies demonstrated that there was no agreement between assessed and measured degree of dehydration which is calculated according to change in body weight at admission and after correction of dehydration. there were tendencies to overestimated or underestimate the degree of dehydration between different physicians. The assessment of the magnitude of dehydration in DKA is of major interest and continues to be a subject of research. This study aims to assess the association between different clinical and laboratory parameters in children with diabetic ketoacidosis and the degree of dehydration at hospital admission among those children.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 1 Hour to 12 Years
Eligibility Inclusion Criteria: - Children with T1DM aged 0-12 years admitted to the pediatric emergency department with DKA criteria (blood glucose level > 200 mg/dl, pH < 7.3, and /or bicarbonate level in blood < 15 mmol/l and positive ketones in urine by dipstick method) will be included. Exclusion Criteria: - Children with DKA who are referred to Sohag university hospital after starting treatment for DKA at another hospital.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
blood and urine samples
complete blood count, blood glucose, blood gases, serum bicarbonates, serum electrolytes, serum albumin ,serum creatinine. blood urea nitrogen, urine analysis.

Locations

Country Name City State
Egypt Sohag University Hospital Sohag

Sponsors (1)

Lead Sponsor Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Raghupathy P. Diabetic ketoacidosis in children and adolescents. Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1):S55-7. doi: 10.4103/2230-8210.155403. — View Citation

Ugale J, Mata A, Meert KL, Sarnaik AP. Measured degree of dehydration in children and adolescents with type 1 diabetic ketoacidosis. Pediatr Crit Care Med. 2012 Mar;13(2):e103-7. doi: 10.1097/PCC.0b013e3182231493. — View Citation

Vicinanza A, Messaaoui A, Tenoutasse S, Dorchy H. Diabetic ketoacidosis in children newly diagnosed with type 1 diabetes mellitus: Role of demographic, clinical, and biochemical features along with genetic and immunological markers as risk factors. A 20-year experience in a tertiary Belgian center. Pediatr Diabetes. 2019 Aug;20(5):584-593. doi: 10.1111/pedi.12864. Epub 2019 May 15. — View Citation

Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, Sperling MA, Codner E. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018 Oct;19 Suppl 27:155-177. doi: 10.1111/pedi.12701. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary measured degree of dehydration calculated as percentage of the difference between the weight at disharge from Picu and the weight at admission to the weight at disharge from Picu 1year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Completed NCT03660189 - Two Bag System for Diabetic Ketoacidosis N/A
Terminated NCT03066440 - Double Blinded Randomized Control Trial of Types of IVF in Children With DKA Phase 4
Completed NCT04940897 - Use of Blood Ketone Meters to Improve Ambulance Hyperglycaemia Care N/A
Completed NCT02930044 - Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis N/A
Completed NCT04926740 - Intravenous Fluids in Adults With Diabetic Ketoacidosis in the Emergency Department N/A
Terminated NCT04567225 - Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management Phase 4
Completed NCT04017221 - Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
Recruiting NCT03717896 - Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis Phase 2
Terminated NCT02548494 - Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes N/A
Completed NCT02006342 - Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis N/A
Completed NCT01753921 - Evaluation of a Non-invasive Brain Compliance Measurement Device
Completed NCT01365793 - Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis Phase 3
Completed NCT00426413 - Ketosis Prone Diabetes in African-Americans N/A
Not yet recruiting NCT05867797 - Risk Factors and Outcomes of Acute Kidney Injury in Patients With Diabetic Ketoacidosis at Sohag University Hospital.
Terminated NCT04234867 - Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) Phase 1
Not yet recruiting NCT05752279 - Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis Phase 3
Completed NCT04825639 - Identifying Risk Factors for Developing AKI in Sepsis
Recruiting NCT05155917 - Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care Phase 2
Completed NCT00629707 - Cerebral Edema in Pediatric Diabetic Ketoacidosis N/A